Despite increasing recognition of lipoprotein(a), or Lp(a), as a significant genetic risk factor for cardiovascular disease (CVD), testing rates for this potentially dangerous particle remain surprisingly low. Experts are raising concerns that many individuals, potentially as many as one in five adults, are unaware they carry elevated levels of Lp(a), leaving them vulnerable to heart attacks, and strokes. This lack of awareness stems from the relatively recent understanding of Lp(a)’s role in heart disease and the fact that it isn’t routinely included in standard cholesterol panels.
Lp(a) is a modified form of low-density lipoprotein (LDL), often referred to as “bad” cholesterol, but unlike LDL, its levels are largely determined by genetics. This means that lifestyle factors like diet and exercise have limited impact on Lp(a) levels, and current medications designed to lower LDL cholesterol don’t necessarily affect it. The discovery of Lp(a)’s significance has been a decades-long process, with research solidifying its status as an independent risk factor for CVD only recently. According to a 2024 review published in The Lancet, Lp(a) is a causal risk factor for CVD in approximately 20% of the global population.
What Makes Lp(a) a Unique Threat?
Lp(a)’s structure includes a protein component known to promote blood clot formation. This characteristic, combined with its genetic basis and resistance to typical cholesterol-lowering interventions, makes it a particularly insidious risk factor. While high levels of Lp(a) can contribute to atherosclerotic cardiovascular disease (ASCVD), leading to plaque buildup in arteries, it can also increase the risk of aortic valve stenosis, a narrowing of the aortic valve.
Dr. Karol Watson, a cardiologist at UCLA Health, explains that Lp(a) levels are determined by genetics, meaning diet, exercise, and medications can’t lower levels. UCLA Health. This contrasts sharply with LDL cholesterol, where lifestyle modifications and medication can often have a significant impact.
Who Should Be Tested for Lp(a)?
Determining who should be tested for Lp(a) is an evolving area of medical guidance. Current recommendations suggest that individuals with a strong family history of early heart disease, particularly those with no traditional risk factors like high blood pressure or high LDL cholesterol, may benefit from Lp(a) testing. Women may seek to consider testing, as Lp(a) concentrations are, on average, 17% higher in women than in men after age 50, potentially linked to menopause. American College of Cardiology. It’s recommended that women who have had an Lp(a) test prior to menopause have it repeated after menopause or at age 50.
New Therapies on the Horizon
The good news is that research into therapies specifically targeting Lp(a) is underway. Several drugs are currently in clinical trials, offering potential hope for individuals with elevated levels. These new treatments represent a significant step forward in addressing a previously untreatable risk factor for heart disease. Harvard Health
The level of Lp(a) is high when the number of kringle IV subtype 2 is low, and vice versa. At low numbers of kringle IV subtype 2, the molecules are freely secreted to attach to circulating LDL particles outside of liver cells to form Lp(a). American College of Cardiology
What’s Next for Lp(a) Research and Clinical Practice?
As research continues to unravel the complexities of Lp(a) and its impact on cardiovascular health, People can expect to notice more refined guidelines for testing and treatment. Increased awareness among both healthcare professionals and the public will be crucial to improving early detection and reducing the burden of heart disease. The development and approval of Lp(a)-targeted therapies promise to revolutionize the management of this often-overlooked risk factor, offering a new avenue for preventing heart attacks and strokes in vulnerable individuals.
Have you discussed your family history of heart disease with your doctor? Share your thoughts in the comments below, and help spread awareness about the importance of understanding your cardiovascular risk factors.
Disclaimer: This article is for informational purposes only and should not be considered medical advice. Please consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
